168 related articles for article (PubMed ID: 2647504)
1. Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition.
Rimoldi MT; Tartanian A; Joiner KA
Exp Parasitol; 1989 Feb; 68(2):160-7. PubMed ID: 2647504
[TBL] [Abstract][Full Text] [Related]
2. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
Joiner K; Sher A; Gaither T; Hammer C
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
[TBL] [Abstract][Full Text] [Related]
3. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
Sher A; Hieny S; Joiner K
J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
Schenkman S; Güther ML; Yoshida N
J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
[TBL] [Abstract][Full Text] [Related]
5. Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components.
Iida K; Whitlow MB; Nussenzweig V
J Exp Med; 1989 Mar; 169(3):881-91. PubMed ID: 2494292
[TBL] [Abstract][Full Text] [Related]
6. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
7. In-vitro lysis of sensitized Trypanosoma cruzi by platelets: role of C3b receptors.
Umekita LF; Mota I
Parasite Immunol; 1989 Sep; 11(5):561-6. PubMed ID: 2531362
[TBL] [Abstract][Full Text] [Related]
8. Binding of complement to trypomastigotes of a Brazil strain of Trypanosoma cruzi: evidence for heterogeneity within the strain.
Jacobson KC; Washburn RG; Kuhn RE
J Parasitol; 1992 Aug; 78(4):697-704. PubMed ID: 1635029
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases.
Joiner KA; daSilva WD; Rimoldi MT; Hammer CH; Sher A; Kipnis TL
J Biol Chem; 1988 Aug; 263(23):11327-35. PubMed ID: 3042767
[TBL] [Abstract][Full Text] [Related]
10. The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies.
Mota I; Umekita LF
Immunol Lett; 1989 Jun; 21(3):223-5. PubMed ID: 2504665
[TBL] [Abstract][Full Text] [Related]
11. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement.
Tomlinson S; Pontes de Carvalho LC; Vandekerckhove F; Nussenzweig V
J Immunol; 1994 Oct; 153(7):3141-7. PubMed ID: 8089492
[TBL] [Abstract][Full Text] [Related]
12. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii: mechanism of resistance to complement-mediated killing.
Fuhrman SA; Joiner KA
J Immunol; 1989 Feb; 142(3):940-7. PubMed ID: 2643665
[TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
15. Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.
Rimoldi MT; Sher A; Heiny S; Lituchy A; Hammer CH; Joiner K
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):193-7. PubMed ID: 3277170
[TBL] [Abstract][Full Text] [Related]
16. gp72, the 72 kilodalton glycoprotein, is the membrane acceptor site for C3 on Trypanosoma cruzi epimastigotes.
Joiner K; Hieny S; Kirchhoff LV; Sher A
J Exp Med; 1985 May; 161(5):1196-212. PubMed ID: 3886827
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.
Joiner KA; Scales R; Warren KA; Frank MM; Rice PA
J Clin Invest; 1985 Nov; 76(5):1765-72. PubMed ID: 3932472
[TBL] [Abstract][Full Text] [Related]
18. Binding of antibody and resistance to lysis of trypomastigotes of Trypanosoma cruzi.
Jacobson KC; Fletcher RC; Kuhn RE
Parasite Immunol; 1992 Jan; 14(1):1-12. PubMed ID: 1557225
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms by which Factor H protects
Menon SS; Ramirez-Toloza G; Wycoff KL; Ehinger S; Shaughnessy J; Ram S; Ferreira VP
Front Immunol; 2024; 15():1152000. PubMed ID: 38361922
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
Sturtevant JE; Balber AE
Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]